These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22096562)

  • 21. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
    Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
    J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
    Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
    BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
    Hamaya S; Fujihara S; Iwama H; Fujita K; Shi T; Nakabayashi R; Mizuo T; Takuma K; Nakahara M; Oura K; Tadokoro T; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Himoto T; Masaki T
    Anticancer Res; 2022 Mar; 42(3):1263-1275. PubMed ID: 35220216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
    Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
    Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma.
    Jin X; Tian S; Li P
    Oncol Res; 2017 Jul; 25(6):939-946. PubMed ID: 27938492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
    Yeung BH; Shek FH; Lee NP; Wong CK
    PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1α-activated TMEM237 promotes hepatocellular carcinoma progression via the NPHP1/Pyk2/ERK pathway.
    Chen T; Wang L; Chen C; Li R; Zhu N; Liu R; Niu Y; Xiao Z; Liu H; Liu Q; Tu K
    Cell Mol Life Sci; 2023 Apr; 80(5):120. PubMed ID: 37041420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kynurenine derivative 3-HAA sensitizes hepatocellular carcinoma to sorafenib by upregulating phosphatases.
    Gan G; Shi Z; Shangguan C; Zhang J; Yuan Y; Chen L; Liu W; Li B; Meng S; Xiong W; Mi J
    Theranostics; 2021; 11(12):6006-6018. PubMed ID: 33897895
    [No Abstract]   [Full Text] [Related]  

  • 34. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
    Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
    Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing
    Zhu Q; Ren H; Li X; Qian B; Fan S; Hu F; Xu L; Zhai B
    Aging (Albany NY); 2020 Nov; 12(22):22975-23003. PubMed ID: 33203790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans.
    Kim Y; Jang M; Lim S; Won H; Yoon KS; Park JH; Kim HJ; Kim BH; Park WS; Ha J; Kim SS
    Hepatology; 2011 Nov; 54(5):1661-78. PubMed ID: 21748762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
    Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
    World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.